FAIRFIELD, Conn.--(BUSINESS WIRE)--Calmare Therapeutics Incorporated, (OTC:CTTC) (CTI), the pain mitigation company, reported results for the year and quarter ended December 31, 2014.
Year Ended December 31, 2014
Revenue from the sale and shipment of the Calmare® pain therapy devices (Devices) for the year ended December 31, 2014 increased 60% or $392,000 to $1,045,000 as compared with $653,000 for the year-ended December 31, 2013.
Help employers find you! Check out all the jobs and post your resume.
